{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T20:27:35Z","timestamp":1794774455745,"version":"4.9.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ijbiomac.2024.129518","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T15:40:27Z","timestamp":1705592427000},"page":"129518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"P1","title":["Exosome co-delivery of a STING agonist augments immunogenicity elicited by CVB3 VP1 vaccine via promoting antigen cross-presentation of CD8 + DCs"],"prefix":"10.1016","volume":"261","author":[{"given":"Changwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijbiomac.2024.129518_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10040603","article-title":"Epidemiological impact of myocarditis","volume":"10","author":"Golpour","year":"2021","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.129518_bb0010","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1053\/j.jvca.2019.12.052","article-title":"Viral myocarditis-incidence, diagnosis and management","volume":"34","author":"Olejniczak","year":"2020","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.129518_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/v12030347","article-title":"Identification of immunogenic epitopes that permit the detection of antigen-specific T cell responses in multiple serotypes of group B Coxsackievirus infections","volume":"12","author":"Lasrado","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2024.129518_bb0020","first-page":"67","article-title":"T lymphocyte responses in CVB3-induced murine myocarditis","volume":"88","author":"Huber","year":"1993","journal-title":"Scand. J. Infect. Dis. Suppl."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.129518_bb0025","article-title":"Vaccines against group B Coxsackieviruses and their importance","volume":"11","author":"Mone","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijbiomac.2024.129518_bb0030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bioactmat.2023.09.018","article-title":"Exosome regulation of immune response mechanism: pros and cons in immunotherapy","volume":"32","author":"Essola","year":"2024","journal-title":"Bioactive Materials"},{"issue":"Pt A","key":"10.1016\/j.ijbiomac.2024.129518_bb0035","article-title":"Exosome-based vaccines and their position in next generation vaccines","volume":"113","author":"Negahdaripour","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129518_bb0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-020-01278-3","article-title":"Exosome-based immunotherapy: a promising approach for cancer treatment","volume":"19","author":"Xu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2024.129518_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.711565","article-title":"Exosome-based vaccines: history, current state, and clinical trials","volume":"12","author":"Santos","year":"2021","journal-title":"Front Immunol"},{"issue":"45","key":"10.1016\/j.ijbiomac.2024.129518_bb0050","doi-asserted-by":"crossref","first-page":"21782","DOI":"10.1039\/C9NR05475H","article-title":"Hybrid nanovaccine for the co-delivery of the mRNA antigen and adjuvant","volume":"11","author":"Yang","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijbiomac.2024.129518_bb0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2022.12.015","article-title":"Exosome-based delivery of VP1 protein conferred enhanced resistance of mice to CVB3-induced viral myocarditis","volume":"579","author":"Zhang","year":"2023","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129518_bb0060","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.129518_bb0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.immuni.2021.10.020","article-title":"Type I interferon activates MHC class I-dressed CD11b(+) conventional dendritic cells to promote protective anti-tumor CD8(+) T cell immunity","volume":"55","author":"Duong","year":"2022","journal-title":"Immunity"},{"issue":"22","key":"10.1016\/j.ijbiomac.2024.129518_bb0070","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00925-21","article-title":"Type I interferon promotes humoral immunity in viral vector vaccination","volume":"95","author":"Zhong","year":"2021","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.129518_bb0075","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2009.07.005","article-title":"Type I interferon signaling in dendritic cells stimulates the development of lymph-node-resident T follicular helper cells","volume":"31","author":"Cucak","year":"2009","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129518_bb0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s40425-019-0635-8","article-title":"Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes","volume":"7","author":"Lu","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.129518_bb0085","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125107","article-title":"The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells","volume":"4","author":"Gutjahr","year":"2019","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.129518_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003351","article-title":"Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants","volume":"9","author":"Conde","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.129518_bb0095","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nchembio.1661","article-title":"Hydrolysis of 2\u20323\u2019-cGAMP by ENPP1 and design of nonhydrolyzable analogs","volume":"10","author":"Li","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2024.129518_bb0100","series-title":"Guide for the Care and Use of Laboratory Animals, Washington (DC)","year":"2011"},{"key":"10.1016\/j.ijbiomac.2024.129518_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100523","article-title":"Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity","volume":"296","author":"McAndrews","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.129518_bb0110","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1073\/pnas.0712394105","article-title":"Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset","volume":"105","author":"Lin","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.129518_bb0115","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.4049\/jimmunol.0803364","article-title":"Novel subset of CD8alpha+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens","volume":"182","author":"Qiu","year":"2009","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.129518_bb0120","article-title":"A novel approach to vaccine development: concomitant pathogen inactivation and host immune stimulation by Peroxynitrite","volume":"10","author":"Rotem","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.129518_bb0125","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/mol.52.2.202","volume":"52","author":"Holmes","year":"1997","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129518_bb0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.immuni.2018.12.027","article-title":"Plasmacytoid dendritic cells: development, regulation, and function","volume":"50","author":"Reizis","year":"2019","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.129518_bb0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41577-018-0088-1","article-title":"Dendritic cell subsets in T cell programming: location dictates function","volume":"19","author":"Eisenbarth","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"33","key":"10.1016\/j.ijbiomac.2024.129518_bb0140","doi-asserted-by":"crossref","first-page":"14745","DOI":"10.1073\/pnas.1001562107","article-title":"CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells","volume":"107","author":"Bar-On","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.129518_bb0145","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2016.08.015","article-title":"Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species","volume":"45","author":"Guilliams","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129518_bb0150","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.0105-2896.2009.00870.x","article-title":"The CD8+ dendritic cell subset","volume":"234","author":"Shortman","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ijbiomac.2024.129518_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104785","article-title":"Redirector of vaccine-induced effector responses (RoVER) for specific killing of cellular targets","volume":"96","author":"Konrad","year":"2023","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.129518_bb0160","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.4049\/jimmunol.2300373","article-title":"cGAS-STING pathway activation during Trypanosoma cruzi infection leads to tissue-dependent parasite control","volume":"211","author":"Perumal","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.129518_bb0165","doi-asserted-by":"crossref","first-page":"1172739","DOI":"10.3389\/fcimb.2023.1172739","article-title":"Interplay between RNA viruses and cGAS\/STING axis in innate immunity","volume":"13","author":"Amurri","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"35","key":"10.1016\/j.ijbiomac.2024.129518_bb0170","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1016\/j.vaccine.2019.07.019","article-title":"The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)\/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells","volume":"37","author":"Volckmar","year":"2019","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.ijbiomac.2024.129518_bb0175","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200568119","article-title":"Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I(+) tumors","volume":"119","author":"Wolf","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.129518_bb0180","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-022-00612-2","article-title":"A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs","volume":"32","author":"Liu","year":"2022","journal-title":"Cell Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.129518_bb0185","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1016\/j.celrep.2018.11.047","article-title":"Magnitude of therapeutic STING activation determines CD8(+) T cell-mediated anti-tumor immunity","volume":"25","author":"Sivick","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.ijbiomac.2024.129518_bb0190","article-title":"cGAS-STING signaling pathway in intestinal homeostasis and diseases","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.129518_bb0195","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1365-2567.2002.01381.x","article-title":"Influence of ageing on Langerhans cell migration in mice: identification of a putative deficiency of epidermal interleukin-1beta","volume":"105","author":"Cumberbatch","year":"2002","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.129518_bb0200","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3892\/etm.2017.4649","article-title":"Comparative study of dendritic cells matured by using IL-1beta, IL-6, TNF-alpha and prostaglandins E2 for different time span","volume":"14","author":"Wu","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.129518_bb0205","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood-2006-05-023465","article-title":"Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha\/beta on antigen cross-presentation","volume":"109","author":"Longman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2024.129518_bb0210","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.yjmcc.2018.08.029","article-title":"Role of neutrophils in CVB3 infection and viral myocarditis","volume":"125","author":"Rivadeneyra","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijbiomac.2024.129518_bb0215","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ebiom.2017.07.016","article-title":"Type I IFN and not TNF, is essential for cyclic Di-nucleotide-elicited CTL by a cytosolic cross-presentation pathway","volume":"22","author":"Lirussi","year":"2017","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.129518_bb0220","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4049\/jimmunol.1301812","article-title":"MPYS\/STING-mediated TNF-alpha, not type I IFN, is essential for the mucosal adjuvant activity of (3\u2032-5\u2032)-cyclic-di-guanosine-monophosphate in vivo","volume":"192","author":"Blaauboer","year":"2014","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.129518_bb0225","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4049\/jimmunol.2000953","article-title":"AdrA as a potential immunomodulatory candidate for STING-mediated antiviral therapy that required both type I IFN and TNF-alpha production","volume":"206","author":"Rodriguez-Garcia","year":"2021","journal-title":"J. Immunol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024003210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024003210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:14:57Z","timestamp":1758885297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024003210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":45,"alternative-id":["S0141813024003210"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129518","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosome co-delivery of a STING agonist augments immunogenicity elicited by CVB3 VP1 vaccine via promoting antigen cross-presentation of CD8 + DCs","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"129518"}}